Learn More
Invitrogen™ CALCOCO2 Monoclonal Antibody (P1813)
Description
Recommended positive controls: Huh-7, Hep3B, HepG2, Jurkat, Raji, NCI-H929, Huh-7 (untreated), Huh-7 (3 μM Thapsigargin treatment for 12 hr), Huh-7 (3 μM Thapsigargin treatment for 24 hr), A.HepG2 (untreated), HepG2 (3 μM Thapsigargin treatment for 12 hr), HepG2 (3 μM Thapsigargin treatment for 24 hr). Predicted reactivity: Human (99%), Chimpanzee (97%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | CALCOCO2 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | P1813 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative |
| Gene | CALCOCO2 |
| Gene Accession No. | A2A6M5, Q13137 |
| Gene Alias | 2410154J16Rik; antigen nuclear dot 52 kDa protein; C77254; calcium binding and coiled-coil domain 2; calcium-binding and coiled-coil domain-containing protein 2; CALCOCO2; Ndp52; Ndp52l1; nuclear domain 10 protein 52; nuclear domain 10 protein 52 like 1; nuclear domain 10 protein NDP52; Nuclear dot protein 52; RGD1559974 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.